Redox-based reagents for methionine bioconjugation
US11353463B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | May 2, 2019 |
| Grant date | Jun 7, 2022 |
| Priority date | — |
| Expiry date | Jul 3, 2039 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2458/15
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Chemoselective conjugation is achieved through redox reactivity by reacting an N-transfer oxidant with a thioether substrate in a redox reaction in an aqueous environment to form a conjugation product. In embodiments, Redox-Activated Chemical Tagging (ReACT) strategies for methionine-based protein functionalization. Oxaziridine (Ox) compounds serve as oxidant-mediated reagents for direct functionalization by converting methionine to the corresponding sulfimide conjugation product.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.